Peter B. Email & Phone Number

Hamburg, Germany

- Bioanalytical Project Manager- Develops and validate biomarker, cell-based, immunogenicity, immuno- and enzymatic assays for - support of preclinical, clinical, and product release studies- Work closely with clients to assure successful on-time execution of assays, validation, and sample analysis under GxP's- Design and execute experiments efficiently.

Hamburg Area, Germany

I am contributing to human health by testing pharmaceutical candidates for safety.

Czech Republic

- making biologics for advanced immunoassays that better portrait cell features. using system oriented synthetic biology.- Supervise team protein engineering efforts.- Propose novel solutions and innovation directions.- Apply rational protein engineering and directed evolution methods for functional optimization with the goal of improving expression.

Singapore

- Development of in silico tools for the Assessment and engineering of raw antibodies from the discover pipeline.- Establishing assays for the biophysical characterisation of antibody candidates- Engineering of antibodies to improve their: developability, effector functions and affinity.- Conversion of antibodies into various recombinant antibody formats.

Cambridge, United Kingdom

I advanced Next Generation Sequencing by providing Technical Support for customers across Europe. I helped with experimental design, troubleshooting, and addressed customer complaints in multiple languages. In addition, I gave recommendations to the customers for the purchase of suitable Next Generation Sequencing products based on their experimental needs.

Singapore

A*STAR, Singapore Immunology Network (SIgN); Antibody Platform (Wang Cheng-I group)PhD position; Award SINGA (A*STAR & Nanyang Technology University)The therapeutic potential of the immunomodulatory cytokine Interleukine-2 is impaired by severe side effects. I engineered bispecific antibodies from phage display derived immunoglobulins to mimic.

Wuerzburg, Germany

CD8+ T cells are thought to be regulated by TGFβ. In contrast, I found that TGFβ boosts the proliferation and function of antigen specifically stimulated CD8+ T cells. I investigated this phenomenon in order to advance the adoptive T cell transfer for the treatment of cancer.. Prof. Dr. med. Schlegel, Dr. med. Woelfl

Frankfurt Am Main, Germany

My diploma thesis contributed to the understanding of interactions between Multidrug resistance transporters and nitro compounds. Using an extensive library of multi-drug resistant cancer cell lines, I assayed drug derivatives for their competitive inhibition of ABC transporter mediated drug resistance. I found that NO- modification of Saquinavir enhanced.

My duties comprised planning and supervision of first-semester practical courses. I supervised 10 students simultaneously. During the course, the relationship between structure and function in biology was explored.